
Clinical-stage proteasome inhibitor that selectively inhibits the chymotrypsin-like activity of the 20S proteasome β5/LMP7 with IC50 of 36 nM/82 nM.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account
Regulatory Status |
RUO – Research Use Only |
---|